Final results of a phase I and pharmacokinetic study of γ-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors

✍ Scribed by Mary Johansen; Thomas Zukowski; PauloM. Hoff; RobertA. Newman; Dan Ni; Toni Hutto; James Abbruzzeese; Elmer Berghorn; Frederick Hausheer; Timothy Madden

• Publisher: Springer
• Year: 2004
• Tongue: English
• Weight: 226 KB
• Volume: 53
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-003-0743-4